Inogen delivered strong second quarter 2025 financial results, with total revenue reaching $92.3 million, a 4.0% increase year-over-year. The company reported a GAAP net loss of $4.2 million but achieved positive adjusted EBITDA of $2.1 million for the second consecutive quarter. This performance led to an increase in full-year 2025 revenue guidance.
Achieved second quarter 2025 revenue of $92.3 million, a 4.0% year-over-year increase, marking the sixth consecutive quarter of mid-single-digit percentage growth.
Delivered adjusted EBITDA of $2.1 million, representing the second consecutive quarter of positive adjusted EBITDA.
Reported a GAAP net loss of $4.2 million and an adjusted net loss of $0.7 million.
Strengthened quarter-end cash, cash equivalents, marketable securities, and restricted cash to $123.7 million with no debt outstanding.
Inogen has raised its full-year 2025 revenue guidance and now expects to reach Adjusted EBITDA breakeven, reflecting confidence in its ongoing turnaround strategy.
Analyze how earnings announcements historically affect stock price performance